BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32727754)

  • 21. Adverse Effects of Preoperative Sarcopenia on Postoperative Complications of Patients With Gastric Cancer.
    Tamura T; Sakurai K; Nambara M; Miki Y; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Yashiro M; Ohira M
    Anticancer Res; 2019 Feb; 39(2):987-992. PubMed ID: 30711985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative low skeletal muscle volume can result in insufficient administration of S-1 adjuvant chemotherapy in older patients with stage II/III gastric cancer.
    Kono Y; Matsunaga T; Makinoya M; Shimizu S; Shishido Y; Miyatani K; Kihara K; Yamamoto M; Takano S; Tokuyasu N; Sakamoto T; Hasegawa T; Fujiwara Y
    Surg Today; 2024 Apr; 54(4):340-346. PubMed ID: 37589768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of skeletal muscle mass in patients with recurrent gastric cancer.
    Matsunaga T; Satio H; Miyauchi W; Shishido Y; Miyatani K; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
    World J Surg Oncol; 2021 Jun; 19(1):170. PubMed ID: 34116681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival Impact of Postoperative Skeletal Muscle Loss in Gastric Cancer Patients Who Underwent Gastrectomy.
    Kuwada K; Kikuchi S; Kuroda S; Yoshida R; Takagi K; Noma K; Nishizaki M; Kagawa S; Umeda Y; Fujiwara T
    Anticancer Res; 2023 Jan; 43(1):223-230. PubMed ID: 36585161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of Post-Gastrectomy Adjuvant S-1 Chemotherapy on Muscle Volume in Gastric Cancer Patients].
    Iwazawa T; Kawanishi K; Fujita J; Takata A; Hirota M; Imamura H; Ikeda A; Hokonohara K; Yoneyama C; Kameyama A; Shinke G; Oshima K; Tanida T; Hatano H; Noda T; Komori T; Morita S; Akagi K; Dono K
    Gan To Kagaku Ryoho; 2015 Aug; 42(8):957-60. PubMed ID: 26321709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sarcopenia Is Associated With Impaired Overall Survival After Gastrectomy for Elderly Gastric Cancer.
    Yamamoto K; Hirao M; Nishikawa K; Omori T; Yanagimoto Y; Shinno N; Sugimura K; Miyata H; Wada H; Takahashi H; Yasui M; Ohue M; Yano M; Fujitani K; Tsujinaka T
    Anticancer Res; 2019 Aug; 39(8):4297-4303. PubMed ID: 31366521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between low preoperative skeletal muscle quality and infectious complications following gastrectomy for gastric cancer.
    Uchida T; Sekine R; Matsuo K; Kigawa G; Umemoto T; Kijima K; Harada Y; Wakabayashi T; Takahashi Y; Shiozawa T; Oyama H; Shibata S; Tanaka K
    Surg Today; 2021 Jul; 51(7):1135-1143. PubMed ID: 33491103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value and Association of Sarcopenia and Systemic Inflammation for Patients with Gastric Cancer Following Radical Gastrectomy.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    Oncologist; 2019 Nov; 24(11):e1091-e1101. PubMed ID: 30910865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative dose intensity and 1-year psoas muscle index reduction rate as prognostic factors in gastric cancer patients with postoperative adjuvant chemotherapy.
    Fujita S; Sakuramoto S; Matsui K; Ebara G; Nishibeppu K; Oya S; Fujihata S; Lee S; Miyawaki Y; Sugita H; Sato H; Yamashita K
    Int J Clin Oncol; 2023 Jan; 28(1):110-120. PubMed ID: 36326962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of preoperative hand grip strength on morbidity following gastric cancer surgery.
    Sato T; Aoyama T; Hayashi T; Segami K; Kawabe T; Fujikawa H; Yamada T; Yamamoto N; Oshima T; Rino Y; Masuda M; Ogata T; Cho H; Yoshikawa T
    Gastric Cancer; 2016 Jul; 19(3):1008-15. PubMed ID: 26466832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of visceral adipose tissue on long-term outcomes after gastrectomy for advanced gastric cancer.
    Matsui R; Inaki N; Tsuji T
    Nutrition; 2022 May; 97():111619. PubMed ID: 35231854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse Effects of Low Preoperative Skeletal Muscle Mass in Patients Undergoing Gastrectomy for Gastric Cancer.
    Sakurai K; Kubo N; Tamura T; Toyokawa T; Amano R; Tanaka H; Muguruma K; Yashiro M; Maeda K; Hirakawa K; Ohira M
    Ann Surg Oncol; 2017 Sep; 24(9):2712-2719. PubMed ID: 28477088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Sarcopenia, Myosteatosis, and the Prognostic Nutritional Index on Survival in Stage 2 and 3 Gastric Cancer Patients.
    Bir Yucel K; Karabork Kilic AC; Sutcuoglu O; Yazıcı O; Aydos U; Kilic K; Özdemir N
    Nutr Cancer; 2023; 75(1):368-375. PubMed ID: 36093734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcopenia and Comorbidity in Gastric Cancer Surgery as a Useful Combined Factor to Predict Eventual Death from Other Causes.
    Kuwada K; Kuroda S; Kikuchi S; Yoshida R; Nishizaki M; Kagawa S; Fujiwara T
    Ann Surg Oncol; 2018 May; 25(5):1160-1166. PubMed ID: 29404820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle Mass, Density, and Strength Are Necessary to Diagnose Sarcopenia in Patients With Gastric Cancer.
    Lin J; Zhang W; Chen W; Huang Y; Wu R; Chen X; Shen X; Zhu G
    J Surg Res; 2019 Sep; 241():141-148. PubMed ID: 31022680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of a Surgical Outcome Risk Tool in patients after radical gastrectomy for gastric cancer and its guiding significance for postoperative chemotherapy.
    Tu RH; Lin JX; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Surg Oncol; 2019 Mar; 28():128-134. PubMed ID: 30851886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic analysis of submucosa-invasive gastric cancer with lymph node metastasis.
    Hanyu T; Matsuki A; Kosugi S; Ishikawa T; Nashimoto A; Yabusaki H; Aizawa M; Ichikawa H; Shimada Y; Hirose Y; Wakai T
    Surgery; 2015 Apr; 157(4):716-22. PubMed ID: 25433728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of risk factor of perioperative complications in patients with radical gastrectomy for gastric cancer and its influence on prognosis].
    Jin J; Deng J; Liang H; Sun C; Guo X; Guo J; Bai H; Liu H; Zhang N
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Jan; 21(1):53-60. PubMed ID: 29354900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the concomitant existence of lymphovascular and perineural invasion in locally advanced gastric cancer patients who underwent curative gastrectomy and adjuvant chemotherapy.
    Hwang JE; Hong JY; Kim JE; Shim HJ; Bae WK; Hwang EC; Jeong O; Park YK; Lee KH; Lee JH; Cho SH; Chung IJ
    Jpn J Clin Oncol; 2015 Jun; 45(6):541-6. PubMed ID: 25759484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.